Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Joshua Gordon

In September 2016, Joshua Gordon joined the NIH as Director of the National Institute of Mental Health (NIMH). For Gordon, who was previously a psychiatrist and neuroscientist at Columbia University Medical Center, this role presented a once-in-a-lifetime opportunity to oversee a US$1.5 billion budget and shape the future of mental health research. When he started, he said his first order of business would be to listen and learn. One year on, he has heard a lot about the institute's classification of mental illnesses for research purposes (known as RDoC), the appropriate balance between basic and clinical research, and the challenges of using genetics to understand psychiatric disease, he told Asher Mullard.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Joshua Gordon. Nat Rev Drug Discov 16, 523–524 (2017).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing